Fat stem cells in orthopedics: Overview, indications and limitations

What are fat stem cells?

In addition to fat cells, adipose tissue contains a cell-rich matrix (stromal vascular fraction, SVF) with mesenchymal stromal cells (often referred to as adipose stem cells), endothelial cells, immune cells and progenitor cells. ADSCs can be isolated from this cell population, which show inflammation-modulating, pain-relieving and tissue-supporting effects in laboratory and animal models.

• Terminology: ADSC = adipose-derived stromal/stem cells (mesenchymal stromal cells from fatty tissue).
• Active principles (hypothesized): Secretion of messenger substances (paracrine effects), modulation of inflammation, support of tissue healing.
• Important: In clinical use, paracrine effects predominate; a real “new formation” of complex tissue is not guaranteed.

Not every fat-based procedure is identical. There are mechanically processed fat (e.g. microfat), emulsions with fewer cells (nanofat) and the enzymatically or mechanically obtained SVF. There are also expanded cell preparations that are generally considered advanced therapy medicinal products (ATMP) in Germany and require strict approvals.

Possible indications – always think conservatively

Fatty stem cell-based procedures are considered in orthopedics primarily for degenerative and overuse-related complaints - typically only after conservative options close to the guidelines have been exhausted. There is no blanket recommendation; Individual suitability is assessed based on anamnesis, examination and imaging.

• Mild to moderate knee osteoarthritis (symptom control, no evidence of new cartilage formation)
• Focal cartilage damage (after orthopedic case-by-case assessment, if necessary in combination with other procedures)
• Chronic tendinopathies (e.g. Achilles tendon, patellar tendon) – only after conservative therapy
• Soft tissue pain near the joints with an inflammatory component

Warning signs such as acute inflammation, infection, severe joint blockages, significant axial misalignments or advanced osteoarthritis with relevant joint space narrowing require different approaches. We provide you with evidence-based advice on this.

Diagnostics and selection criteria

Every decision requires a thorough clarification. The aim is to precisely identify the cause of pain, recognize accompanying factors and carry out a realistic risk-benefit assessment.

• History, physical examination, functional analysis
• Imaging depending on the question (e.g. X-ray if the degree of osteoarthritis is present, if necessary MRI if there is cartilage/soft tissue involvement)
• Comparison with conservative options (physiotherapy, activity modification, orthoses, pain management, if necessary hyaluronic acid/PRP)
• Exclusion of contraindications (infections, coagulation disorders, immunosuppressive therapies, pregnancy, unexplained swellings)

Process and variants at a glance

Various technical approaches are summarized under the umbrella term “fat stem cells”. They differ in cell content, production, regulatory status and objectives. Careful selection and education is crucial.

• Microfragmented fat (microfat): mechanically prepared autologous fat with preserved microarchitecture; The aim is an injection that is gentle on the tissue. See subpage: Microfragmented fat (Microfat).
• Nanofat: highly emulsified/filtered fat with very few adipose cells; rather cell-free matrix and signaling effects. See subpage: Nanofat therapy.
• Stromal Vascular Fraction (SVF): cell-rich fraction from adipose tissue; obtained enzymatically or mechanically. Particularly sensitive from a regulatory perspective. See subpage: Stromal Vascular Fraction (SVF).
• Bone marrow stem cells: alternative source of mesenchymal stromal cells; different sampling, different evidence. See subpage: Bone marrow stem cells.
• Cell-cultured/expanded ADSC: in Germany basically ATMP with approval/approval requirement; not regularly available outside of approved studies/structures.

Combination approaches (e.g. microfat with PRP) are also being researched. Robust, long-term randomized studies are lacking for many combinations. A benefit assessment is carried out on a case-by-case basis.

Procedure for a fat-based injection (example)

The specific process depends on the procedure chosen and the legal framework. Below is a typical scheme for mechanically prepared autologous fat:

Duration: usually 45-90 minutes including preparation and rest. Ability to work and play sports are discussed individually; Heavy loads should be avoided initially.

Evidence: What is proven, what is still open?

The clinical study situation on fat stem cells in orthopedics is growing, but is heterogeneous. There are prospective studies and some randomized studies that show an improvement in pain and function over months to a few years in mild to moderate osteoarthritis. Structural regeneration (e.g. stable cartilage formation) has not yet been reliably proven.

• Symptom improvement: possible in selected collectives; Effect size varies.
• Long-term data: limited; Sustainable benefits over several years are not guaranteed.
• Comparisons: compared to placebo/standard therapy, some advantages, some no differences.
• Heterogeneity: large differences in procedures, concentrations, endpoints, follow-up duration.
• Conclusion: no general standard; Individual benefit-risk assessment and realistic expectations are central.

Risks, side effects and limitations

Like any invasive procedure, there are inherent risks to fat-based injections. Serious complications are rare but can occur. Careful indication, sterile technique and image-guided injection reduce risks, but do not eliminate them.

• Local reactions: pain, swelling, hematomas at the removal and injection site.
• Infection: rare but serious; Strict hygiene and follow-up are mandatory.
• Nerve/vascular irritation, temporary sensory disorders.
• Fatty tissue reactions (e.g. small necrosis/nodules) are rarely possible.
• Risk of thrombosis: low, consider individual risk factors.
• Limitations: advanced osteoarthritis, significant misalignments, mechanical instability tend to speak against the benefit of injection treatment.

Regulation in Germany: What is allowed?

The legal classification depends heavily on the procedure. Mechanically minimally manipulated autologous fat for re-injection is subject to different requirements than enzymatic isolation of cells or cell culture expansion. Enzymatically derived SVF and expanded ADSC are generally classified as advanced therapy medicinal products (ATMP) and require appropriate approvals or approvals.

• Minimal manipulation: mechanical processing may be permissible under certain conditions, depending on the system and use.
• SVF (enzymatic): generally requires approval in Germany (ATMP context).
• Individual attempt at healing: outside of approved standard therapies, use as an individual attempt at healing can be considered - with detailed information.
• We provide transparent advice on regulatory aspects and only offer procedures that are responsible in compliance with the applicable requirements.

Who can benefit from fat stem cell therapy?

A fat-based injection is more suitable for patients with local complaints that have responded inadequately to conservative therapy without already having severe structural damage or relevant axial deviations.

• Mild to moderate osteoarthritis (clinically and imaging-matched)
• Sufficient amount of fatty tissue for removal
• Realistic expectations (symptom relief possible, no promise of cure)

Contraindications (selection):

• Acute infections, wound healing disorders
• Uncontrolled coagulation disorders, anticoagulation without adjustment option
• Pregnancy, breastfeeding
• Certain systemic diseases or immunosuppressive therapies
• Missing indication (e.g. advanced osteoarthritis with mechanical instability)

Conservative alternatives and combinations

Before every regenerative measure, we consistently examine conservative strategies. This can often be used to reduce pain and improve function - sometimes in combination with activity control that is gentle on the joints.

• Physiotherapy: muscular balance, mobility, coordination
• Activity and stress management, workplace adaptation
• Weight management for osteoarthritis
• Orthoses, insoles, aids
• Drug pain therapy as needed and tolerated
• Injection therapies: e.g. B. Hyaluronic acid, PRP (autologous blood) depending on evidence and indication
• Surgical options if conservative measures fail (e.g. corrective osteotomy, endoprosthetics) – only if sensible

Aftercare and rehabilitation

Follow-up treatment is a central component of overall success. We combine the injection – if carried out – with a structured, step-by-step rehabilitation plan.

• Short-term relief/rest, then gradual increase in load
• Physiotherapy with a focus on pain-adapted training
• feedback on progress; Adjustment of the plan depending on symptoms
• Check-up appointments to evaluate function, pain and activity level

Your orthopedics in Hamburg: transparent and individual

In our practice at Dorotheenstrasse 48, 22301 Hamburg, we provide you with individual, evidence-based advice. Our approach: conservative first; regenerative processes only where they appear sensible and responsible. We take the time to make an honest assessment – ​​without any promises of salvation.

We would be happy to check whether a fat stem cell-based procedure is suitable for your situation or whether other treatments are a priority. Make an appointment - we will clarify your questions and plan the next steps together.

Related topics and in-depth subpages

The following pages explain specific procedures and alternatives in detail. They help to classify which method can be considered in which constellation.

• Microfragmented fat (microfat): process, evidence, indications
• Nanofat therapy: properties, differences from microfat
• Stromal Vascular Fraction (SVF): Potentials and Regulatory Aspects
• Bone marrow stem cells: comparison to fat-based approaches
• Ear cartilage-based chondrocytes: option for focal cartilage damage in special scenarios

Costs and reimbursement

Fat stem cell-based procedures are generally not covered by statutory health insurance companies. Private reimbursements depend on the case and require prior clarification. If requested, we will prepare a cost estimate and support you with the documentation.

• Self-pay service in many cases
• Individual reimbursement through private insurance possible, but not guaranteed
• Transparent cost explanation before every measure